3Hanauske AR, Degen D, Hilsenbeck SG, et al. Effects of Taxo-tere and taxol on invitro colony formation off reshty explanted human tumor cells[ J]. Anticancer Drugs, 1992,3: 121 - 124.
4Kelland LR, Abel G. Comparative inviteovey totoxicity of taxol and Taxotere against eisplatin sensitiveand resistant human ovarian carcinoma cell limes[ J]. Cancer Chemother Pbarmaeol, 1992,30: 444 - 450.
二级参考文献26
1Francis PA, Rigas JR, Kris MG, et al. Phase Ⅱ trial of docetaxel in patients in with stage Ⅲ and Ⅳ non-small cell lung cancer. J Clin Oncol,1994, 12: 1232-1237.
2Hainsworth JD,Burris Ⅲ HA, Greco FA. Weekly Administration of Docetaxel (Taxotere): summary of clinical data. Semin Oncol,1999,26( Suppl 10) : 19-24.
3Fossella FV, Lee JS, Murphy WK, et al. Phase Ⅱ study of docetaxel for recurrent or metastatic non small cell lung cancer. J Clin 0ncol, 1994, 12: 1238-1244.
4Fossella FV, Lee JS, Berilh J, et al. Summary of phase Ⅱ data of docetaxel(Taxotere), an active agent in the first and second line treatment of advanced non small cell lung cancer. Semin Oneol,1995, 22(2 Suppl 4) :22-29.
5Belani CP. Single agents in the second line treatment of non small cell lung cancer. Semin 0neol,1998, 25(3 Suppl 8) : 10-14.
6Ravdin PM, Bun'is HA, Cook G, et al. Phase Ⅱ trial of docetaxel inadvanced anthracicline-resistant or anthracenedione-resistant breast cancer. J Clin 0ncol,1995, 13:2879-2885.
7Kubota K, Watanabe K, Kunitoh H,et al. Phase Ⅲ randomized trial of decetaxel plus cisplatin versus vindesine plus cispaltin in patients with stage Ⅳ non small cell lung cancer: the Japanese Taxotere Lung Cancer Study Group. J Clin Oncol, 2004, 22:354-261.
8Fossella F, Pereira JR, von Pawel JV, et al. Bandomezed,multinational, phase Ⅲ study of decetaxel plus platinum combination versus vinorelbine plus cisplatin for advanced non small cell lungcancer: the TAX 326 study group. J Clin Oncol,2003,21:3016-3024.
9Koizumi T, Tsunoda T, Fujimoto K, et al. Phase Ⅰ trial of weekly docetaxel combined with cisplatin in patients with non small cell lung cancer. Lung Cancer, 2001, 34 : 125-131.
10Ohe Y, Niho S, Kakinuma B, et al. Phase I trial of cisplafin and docetaxel administered by three consecutive weekly infusion for advanced non small cell lung cancer in elderly and non elderly patients. Jpn J Clin Oncol, 2001, 31 : 100-106.
4Singletary SE,Allred C,Ashley P,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer[ J]. J Clin Oncol,2002,20(17) : 3 628 -3 636.
5O' Shaughnessy J, Miles D, Vukelja S, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracyclinepretreated patients with advanced breast cancer. Phase III trial resuits[J]. J Clin Oncol,2002,20(12):2 812 -2 823.
